![Daré Bioscience, Inc. logo](/logos/DARE.webp)
Daré Bioscience, Inc.
NASDAQ:DARE
Overview | Financials
Company Name | Daré Bioscience, Inc. |
Symbol | DARE |
Currency | USD |
Price | 3.42 |
Market Cap | 29,228,551 |
Dividend Yield | 0% |
52-week-range | 3.05 - 7.56 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Ms. Sabrina Martucci Johnson |
Website | https://www.darebioscience.com |
An error occurred while fetching data.
About Daré Bioscience, Inc.
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription product for the treatment
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD